Jack Dean

Jack Hugh Dean was the founder of Dipexium Pharmaceuticals, Inc. since 2010, holding the title of Director from 2010 to 2014.
Current jobs include Director at ReSearch Pharmaceutical Services LLC since 2008, Independent Director at Acurx Pharmaceuticals, Inc. since 2021, President at Drug Development Advisors LLC since 2006, Trustee at ILSI Health & Environmental Sciences Institute since 1994, and Professor at the University of Arizona College of Pharmacy since 2006.
Former jobs include Global Director-Preclinical Development at Sanofi from 1988 to 2006, Director at PLx Pharma, Inc. from 2010 to 2017, Director at Sanofi-Synthelabo, Inc., Director at Sterling Winthrop Pharmaceuticals Research Center from 1990 to 1992, Director-Department of Immunology at Litton Bionetics, Inc. from 1975 to 1979, Professor at UNC Chapel Hill Foundation Investment Fund, Inc. from 1981 to 1988, Vice President-Drug Safety at Sterling Winthrop, Inc. from 1989 to 1992, Head-National Toxicology Program at National Institutes of Health from 1982 to 1988, President-US Science & Medical Affairs at Sanofi-Aventis U.S.
LLC from 1988 to 2006, Head-Immunotoxicology Section at The National Institute of Environmental Health Sciences from 1982 to 1988, and Head-Cellular & Molecular Toxicology Department at The Hamner Institutes for Health Sciences from 1982 to 1988.
Education includes undergraduate and graduate degrees from The California State University and a doctorate from the University of Arizona College of Medicine conferred in 1972.